|
|
||||||||
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
Key Words. Stem cells • Pancreatic islet • Differentiation • Multipotent stem cells • Diabetes
Correspondence: Nadya Lumelsky, Ph.D., Islet and Autoimmunity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, CRC, Room 5-5940, 10 Center Drive, Bethesda, Maryland 20892-1453, USA. Telephone: 301-451-9834; Fax: 301-480-1269; e-mail: nadyal{at}intra.niddk.nih.gov
Strategies designed to produce functional cells from stem cells or from mature cells hold great promise for treatment of different cell-degenerative diseases. Type 1 and type 2 diabetes are examples of such diseases. Although different in origin, both involve inadequate cell mass of insulin-producing ß cells, the most abundant cell type of pancreatic islets of Langerhans. Practical realization of such strategies is highly dependent on the elucidation of physiological mechanisms responsible for generation of new ß cells in the pancreas, which at this time are poorly defined. The in vitro differentiation systems allowing generation of new ß cells provide a valuable experimental tool for studying these mechanisms. Few such systems are currently available. In this work, we present an in vitro differentiation system, derived from adult mouse pancreas, capable of generating insulin-producing ß-like cells, which self-organize into islet-like cell clusters (ILCCs) during the course of the culture. Surprisingly, we found that along with the ILCCs, multiple cell types with phenotypic characteristics of embryonic central nervous system and neural crest are also generated. Moreover, several embryonic stem cellspecific genes are induced during the course of these cultures. These results suggest that the adult pancreas may contain cells competent to give rise to new endocrine and neural cells.
This article has been cited by other articles:
![]() |
F. Atouf, C. H. Park, K. Pechhold, M. Ta, Y. Choi, and N. L. Lumelsky No Evidence for Mouse Pancreatic {beta}-Cell Epithelial-Mesenchymal Transition In Vitro Diabetes, March 1, 2007; 56(3): 699 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Danner, J. Kajahn, C. Geismann, E. Klink, and C. Kruse Derivation of oocyte-like cells from a clonal pancreatic stem cell line Mol. Hum. Reprod., January 1, 2007; 13(1): 11 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bauer, L. K. Yu, G. D. Demetri, and J. A. Fletcher Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor. Cancer Res., September 15, 2006; 66(18): 9153 - 9161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ta, Y. Choi, F. Atouf, C. H. Park, and N. Lumelsky The Defined Combination of Growth Factors Controls Generation of Long-Term-Replicating Islet Progenitor-Like Cells from Cultures of Adult Mouse Pancreas Stem Cells, July 1, 2006; 24(7): 1738 - 1749. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
